Yield Pharma, located in Suzhou, China, is a biochemistry company providing building blocks, intermediates, APIs and electron compounds. As a research driven and custom-orientated company, Yield pharma offers global pharmaceutical and electronic manufactors a broad and integrated services of laboratory research and mass manufacturing. Yield pharma has a competitive team of scientific research, professional apparatus and an advanced management system. With the help of these, Yield successfully developed the synthesizing processes in industrial production of EDOT, N. N-dimethylsulfamide, 4, 6-Dichloro-5-(2-methoxyphenoxy)[2, 2']bipyrimidinyl, Cyclopropane sulfonamide and Cyclopropanesulfonyl chloride, among which, EDOT and N. N-dimethylsulfamide are ISO 9001 certified, and also developed the pilot process of some pharmaceutical intermediates and APIs, such as 2, 5-dichloropyrimidine and quinoline boronic acid, etc. Besides, Yield has applied the patent of synthesis process of EDOT(CN101220038), 2-chloro-5-aminopyrimidine(CN101219997)and 4, 6-Dichloro-5-(2-methoxyphenoxy)[2, 2']bipyrimidinyl(CN101279984). The head quarter of Yield lies in Suzhou Industrial Park. Its R&D center, located in Nanjing Yuhua Economic Development Zone, covers 1000 square meters. The pilot-plant of Yield is in Shipai Town of Kunshan with an area of 31122.6 square meters. There is also a manufacturing factory in located in Jiangsu Yancheng Binhai Economic Development Zone with an area of 35 acres.
